280 related articles for article (PubMed ID: 17259793)
1. Islet cell, thyroid, adrenal and celiac disease related autoantibodies in patients with Type 1 diabetes from Sri Lanka.
Premawardhana LD; Wijeyaratne CN; Chen S; Wijesuriya M; Illangasekera U; Brooking H; Amoroso M; Jeffreys J; Bolton J; Lazarus JH; Furmaniak J; Rees Smith B
J Endocrinol Invest; 2006 Dec; 29(11):968-74. PubMed ID: 17259793
[TBL] [Abstract][Full Text] [Related]
2. Coincidence of high antiislet and antithyroid autoantibody titles in first-degree relatives of patients with type 1 diabetes.
Sougioultzoglou F; Falorni A; Kassi G; Brozzetti A; Karamitsos D; Koliakos GG
Exp Clin Endocrinol Diabetes; 2005 Feb; 113(2):85-9. PubMed ID: 15772899
[TBL] [Abstract][Full Text] [Related]
3. Comparative analysis of organ-specific autoantibodies and celiac disease--associated antibodies in type 1 diabetic patients, their first-degree relatives, and healthy control subjects.
Jaeger C; Hatziagelaki E; Petzoldt R; Bretzel RG
Diabetes Care; 2001 Jan; 24(1):27-32. PubMed ID: 11194235
[TBL] [Abstract][Full Text] [Related]
4. Childhood thyroid autoimmunity and relation to islet autoantibodies in children at risk for type 1 diabetes in the diabetes prediction in skåne (DiPiS) study.
Jonsdottir B; Larsson C; Lundgren M; Ramelius A; Jönsson I; Larsson HE;
Autoimmunity; 2018 Aug; 51(5):228-237. PubMed ID: 30486698
[TBL] [Abstract][Full Text] [Related]
5. Increased risk for endocrine autoimmunity in Italian type 2 diabetic patients with GAD65 autoantibodies.
Gambelunghe G; Forini F; Laureti S; Murdolo G; Toraldo G; Santeusanio F; Brunetti P; Sanjeevi CB; Falorni A
Clin Endocrinol (Oxf); 2000 May; 52(5):565-73. PubMed ID: 10792335
[TBL] [Abstract][Full Text] [Related]
6. Tyrosine phosphatase-like protein (IA-2) and glutamic acid decarboxylase (GAD65) autoantibodies: a study of Chinese patients with diabetes mellitus.
Ng WY; Lee YS; Todd AL; Lui KF; Loke KY; Thai AC
Autoimmunity; 2002 Mar; 35(2):119-24. PubMed ID: 12073931
[TBL] [Abstract][Full Text] [Related]
7. Expression of endocrine autoantibodies in chronic hepatitis C, before and after interferon-alpha therapy.
Murdolo G; Francisci D; Forini F; Baldelli F; Angeletti G; Stagni G; Santeusanio F; Calcinaro F; Falorni A
J Endocrinol Invest; 2002 Dec; 25(11):938-46. PubMed ID: 12553552
[TBL] [Abstract][Full Text] [Related]
8. Autoantibody "subspecificity" in type 1 diabetes: risk for organ-specific autoimmunity clusters in distinct groups.
Barker JM; Yu J; Yu L; Wang J; Miao D; Bao F; Hoffenberg E; Nelson JC; Gottlieb PA; Rewers M; Eisenbarth GS
Diabetes Care; 2005 Apr; 28(4):850-5. PubMed ID: 15793184
[TBL] [Abstract][Full Text] [Related]
9. The evaluation of thyroid and islet autoantibodies in type 1 diabetes mellitus.
Prázný M; Skrha J; Límanová Z; Hilgertová J
Sb Lek; 1999; 100(3):205-11. PubMed ID: 11221467
[TBL] [Abstract][Full Text] [Related]
10. Frequency of islet cell autoantibodies (IA-2 and GAD) in young Brazilian type 1 diabetes patients.
Pardini VC; Mourao DM; Nascimento PD; Vívolo MA; Ferreira SR; Pardini H
Braz J Med Biol Res; 1999 Oct; 32(10):1195-8. PubMed ID: 10510254
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of beta-cell and thyroid autoantibody positivity in schoolchildren during three-year follow-up.
Lindberg B; Carlsson A; Ericsson UB; Kockum I; Lernmark A; Landin-Olsson M; Sundkvist G; Ivarsson SA
Autoimmunity; 1999; 31(3):175-85. PubMed ID: 10739334
[TBL] [Abstract][Full Text] [Related]
12. Autoantibodies predicting diabetes mellitus type I in celiac disease.
Galli-Tsinopoulou A; Nousia-Arvanitakis S; Dracoulacos D; Xefteri M; Karamouzis M
Horm Res; 1999; 52(3):119-24. PubMed ID: 10725775
[TBL] [Abstract][Full Text] [Related]
13. Ketoacidosis in young adults is not related to the islet antibodies at the diagnosis of Type 1 diabetes mellitus--a nationwide study.
Ostman J; Landin-Olsson M; Törn C; Palmer J; Lernmark A; Arnqvist H; Björk E; Bolinder J; Blohmé G; Eriksson J; Littorin B; Nyström L; Scherstén B; Sundkvist G; Wibell L
Diabet Med; 2000 Apr; 17(4):269-74. PubMed ID: 10821292
[TBL] [Abstract][Full Text] [Related]
14. Glutamic acid decarboxylase and ICA512/IA-2 autoantibodies as disease markers and relationship to residual beta-cell function and glycemic control in young type 1 diabetic patients.
Zanone MM; Catalfamo E; Pietropaolo SL; Rabbone I; Sacchetti C; Cerutti F; Trucco M; Cavallo-Perin P
Metabolism; 2003 Jan; 52(1):25-9. PubMed ID: 12524658
[TBL] [Abstract][Full Text] [Related]
15. Screening for associated autoimmunity in type 1 diabetes mellitus with respect to diabetes control.
Prázný M; Skrha J; Límanová Z; Vanícková Z; Hilgertová J; Prázná J; Jaresová M; Stríz I
Physiol Res; 2005; 54(1):41-48. PubMed ID: 15717840
[TBL] [Abstract][Full Text] [Related]
16. Organ-specific autoantibodies in Chinese patients newly diagnosed with type 1 diabetes mellitus.
Pan S; Wu T; Shi X; Xie Z; Huang G; Zhou Z
Endocr J; 2020 Jul; 67(7):793-802. PubMed ID: 32295990
[TBL] [Abstract][Full Text] [Related]
17. Autonomic function and autoantibodies to autonomic nervous structures, glutamic acid decarboxylase and islet tyrosine phosphatase in adolescent patients with IDDM.
Zanone MM; Burchio S; Quadri R; Pietropaolo M; Sacchetti C; Rabbone I; Chiandussi L; Cerutti F; Peakman M
J Neuroimmunol; 1998 Jul; 87(1-2):1-10. PubMed ID: 9670839
[TBL] [Abstract][Full Text] [Related]
18. Anti-glutamate decarboxylase and other antibodies at the onset of childhood IDDM: a population-based study.
Verge CF; Howard NJ; Rowley MJ; Mackay IR; Zimmet PZ; Egan M; Hulinska H; Hulinsky I; Silvestrini RA; Kamath S
Diabetologia; 1994 Nov; 37(11):1113-20. PubMed ID: 7867883
[TBL] [Abstract][Full Text] [Related]
19. Combined screening for autoantibodies to IA-2 and antibodies to glutamic acid decarboxylase in first degree relatives of patients with IDDM. The DENIS Study Group. Deutsche Nikotinamid Interventions-Studie.
Seissler J; Morgenthaler NG; Achenbach P; Lampeter EF; Glawe D; Payton M; Christie M; Scherbaum WA
Diabetologia; 1996 Nov; 39(11):1351-6. PubMed ID: 8933004
[TBL] [Abstract][Full Text] [Related]
20. Autoantibodies against glutamic acid decarboxylase and 21-hydroxylase in Brazilian patients with type 1 diabetes or autoimmune thyroid diseases.
Silva RC; Sallorenzo C; Kater CE; Dib SA; Falorni A
Diabetes Nutr Metab; 2003 Jun; 16(3):160-8. PubMed ID: 14635733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
